Literature DB >> 31336335

Research progress on the anti-hepatic fibrosis action and mechanism of natural products.

Liang Shan1, Zhenni Liu1, Leilei Ci1, Chen Shuai1, Xiongwen Lv2, Jun Li1.   

Abstract

Hepatic fibrosis is the most common pathological feature of most chronic liver diseases, and its continuous deterioration gradually develops into liver cirrhosis and eventually leads to liver cancer. At present, there are many kinds of drugs used to treat liver fibrosis. However, Western drugs tend to only target single genes/proteins and induce many adverse reactions. Most of the mechanisms and active ingredients of traditional Chinese medicine (TCM) are not clear, and there is a lack of unified diagnosis and treatment standards. Natural products, which are characterized by structural diversity, low toxicity, and origination from a wide range of sources, have unique advantages and great potential in anti-liver fibrosis. This article summarizes the work done over the previous decade, on the active ingredients in natural products that are reported to have anti-hepatic fibrosis effects. The effective anti-hepatic fibrosis ingredients identified can be generally divided into flavonoids, saponins, polysaccharides and alkaloids. Mechanisms of anti-liver fibrosis include inhibition of liver inflammation, anti-lipid peroxidation injury, inhibition of the activation and proliferation of hepatic stellate cells (HSCs), modulation of the synthesis and secretion of pro-fibrosis factors, and regulation of the synthesis and degradation of the extracellular matrix (ECM). This review provides suggestions for the development of anti-hepatic fibrosis drugs.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-hepatic fibrosis; HSC; Mechanism; Natural product; Research progress

Mesh:

Substances:

Year:  2019        PMID: 31336335     DOI: 10.1016/j.intimp.2019.105765

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  16 in total

1.  Anti-liver fibrosis effects of the total flavonoids of litchi semen on CCl4-induced liver fibrosis in rats associated with the upregulation of retinol metabolism.

Authors:  Jiongyi Yan; Yinyi Feng; Xuewan Fang; Xiaojuan Cui; Xing Xia; Fang Li; Weisheng Luo; Jianqin Liang; Jianfang Feng; Kai Yu
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

2.  LRP6-CRISPR prevents activation of hepatic stellate cells and liver fibrogenesis in rats.

Authors:  Linghua Yu; Linlin Wang; Huixing Yi; Xiaojun Wu
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

3.  Polyporus Polysaccharide Ameliorates Bleomycin-Induced Pulmonary Fibrosis by Suppressing Myofibroblast Differentiation via TGF-β/Smad2/3 Pathway.

Authors:  Jintao Jiang; Fang Wang; Aishu Luo; Shiyu Lin; Xiaoke Feng; Wei Yan; Yumeng Shi; Qian Zhang; Xin Gu; Guoliang Cui; Jianan Wang; Lei Wang; Qiande Zhang; Wenfeng Tan
Journal:  Front Pharmacol       Date:  2020-05-26       Impact factor: 5.810

4.  Forsythiaside A Regulates Activation of Hepatic Stellate Cells by Inhibiting NOX4-Dependent ROS.

Authors:  Mengting Zhou; Xingtao Zhao; Li Liao; Ying Deng; Meichen Liu; Jing Wang; Xinyan Xue; Yunxia Li
Journal:  Oxid Med Cell Longev       Date:  2022-01-05       Impact factor: 6.543

5.  Indole-3-propionic Acid-aggravated CCl4-induced Liver Fibrosis via the TGF-β1/Smads Signaling Pathway.

Authors:  Fei Liu; Changfeng Sun; Yuanfang Chen; Fei Du; Yuxiang Yang; Gang Wu
Journal:  J Clin Transl Hepatol       Date:  2021-05-17

Review 6.  Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis.

Authors:  Fa-Da Wang; Jing Zhou; En-Qiang Chen
Journal:  Front Pharmacol       Date:  2022-02-11       Impact factor: 5.810

7.  Resveratrol Alleviates Hepatic Fibrosis in Associated with Decreased Endoplasmic Reticulum Stress-Mediated Apoptosis and Inflammation.

Authors:  Zhenyu Ma; Lulu Sheng; Juan Li; Jianmin Qian; Gang Wu; Zhengxin Wang; Yi Zhang
Journal:  Inflammation       Date:  2022-01-26       Impact factor: 4.092

8.  Integrated analysis of differentially expressed genes, differentially methylated genes, and natural compounds in hepatitis C virus-induced cirrhosis.

Authors:  Junxiong Cheng; Zhiwei Chen; Guoqing Zuo; Wenfu Cao
Journal:  J Int Med Res       Date:  2022-01       Impact factor: 1.671

9.  Effects of salvianolic acid B on liver fibrosis: A protocol for systematic review and meta analysis.

Authors:  Xiaocong Ma; Meiwen Tang; Liying Lu; Jinghui Zheng; Jingjing Huang; Junhong Li; Weisheng Luo
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

10.  TIM-4 interference in Kupffer cells against CCL4-induced liver fibrosis by mediating Akt1/Mitophagy signalling pathway.

Authors:  Hao Wu; Guoyong Chen; Jingyuan Wang; Minghua Deng; Fangchao Yuan; Jianping Gong
Journal:  Cell Prolif       Date:  2019-11-22       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.